APA (7th ed.) Citation

Cohen, C., Green, J., Olivet, H., Khanlou, H., Burman, W., Corales, R., . . . Garb, J. (2012). A randomized pilot study of tenofovir/emtricitabine (TDF/FTC) + boosted atazanavir (ATV/r) vs. raltegravir (RAL BID) + ATV/r vs. RAL BID + ATV BID. Journal of the International AIDS Society, 15, 1. https://doi.org/10.7448/IAS.15.6.18279

Chicago Style (17th ed.) Citation

Cohen, C., et al. "A Randomized Pilot Study of Tenofovir/emtricitabine (TDF/FTC) + Boosted Atazanavir (ATV/r) Vs. Raltegravir (RAL BID) + ATV/r Vs. RAL BID + ATV BID." Journal of the International AIDS Society 15 (2012): 1. https://doi.org/10.7448/IAS.15.6.18279.

MLA (9th ed.) Citation

Cohen, C., et al. "A Randomized Pilot Study of Tenofovir/emtricitabine (TDF/FTC) + Boosted Atazanavir (ATV/r) Vs. Raltegravir (RAL BID) + ATV/r Vs. RAL BID + ATV BID." Journal of the International AIDS Society, vol. 15, 2012, p. 1, https://doi.org/10.7448/IAS.15.6.18279.